Búsqueda | Biblioteca Virtual en Salud

1.

Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer.

Turner, N C; Swift, C; Jenkins, B; Kilburn, L; Coakley, M; Beaney, M; Fox, L; Goddard, K; Garcia-Murillas, I; Proszek, P; Hall, P; Harper-Wynne, C; Hickish, T; Kernaghan, S; Macpherson, I R; Okines, A F C; Palmieri, C; Perry, S; Randle, K; Snowdon, C; Stobart, H; Wardley, A M; Wheatley, D; Waters, S; Winter, M C; Hubank, M; Allen, S D; Bliss, J M.

Ann Oncol ; 34(2): 200-211, 2023 02.

Artículo en Inglés | MEDLINE | ID: mdl-36423745

2.

Tracking evolution of aromatase inhibitor resistance with circulating tumour DNA analysis in metastatic breast cancer.

Fribbens, C; Garcia Murillas, I; Beaney, M; Hrebien, S; O'Leary, B; Kilburn, L; Howarth, K; Epstein, M; Green, E; Rosenfeld, N; Ring, A; Johnston, S; Turner, N.

Ann Oncol ; 29(1): 145-153, 2018 01 01.

Artículo en Inglés | MEDLINE | ID: mdl-29045530

3.

JNO special issue: an update on pediatric neuro-oncology.

Kilburn, L B; Packer, Roger J.

J Neurooncol ; 150(1): 1-4, 2020 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-32845498

4.

NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer.

Palmieri, C; Cleator, S; Kilburn, L S; Kim, S B; Ahn, S-H; Beresford, M; Gong, G; Mansi, J; Mallon, E; Reed, S; Mousa, K; Fallowfield, L; Cheang, M; Morden, J; Page, K; Guttery, D S; Rghebi, B; Primrose, L; Shaw, J A; Thompson, A M; Bliss, J M; Coombes, R C.

Breast Cancer Res Treat ; 148(3): 581-90, 2014 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-25395314

5.

Long-term assessment of quality of life in the Intergroup Exemestane Study: 5 years post-randomisation.

Fallowfield, L J; Kilburn, L S; Langridge, C; Snowdon, C F; Bliss, J M; Coombes, R C.

Br J Cancer ; 106(6): 1062-7, 2012 Mar 13.

Artículo en Inglés | MEDLINE | ID: mdl-22353807

6.

Adjuvant chemotherapy in older women (ACTION) study - what did we learn from the pilot phase?

Leonard, R; Ballinger, R; Cameron, D; Ellis, P; Fallowfield, L; Gosney, M; Johnson, L; Kilburn, L S; Makris, A; Mansi, J; Reed, M; Ring, A; Robinson, A; Simmonds, P; Thomas, G; Bliss, J M.

Br J Cancer ; 105(9): 1260-6, 2011 Oct 25.

Artículo en Inglés | MEDLINE | ID: mdl-21989185

7.

Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial.

Coombes, R C; Kilburn, L S; Snowdon, C F; Paridaens, R; Coleman, R E; Jones, S E; Jassem, J; Van de Velde, C J H; Delozier, T; Alvarez, I; Del Mastro, L; Ortmann, O; Diedrich, K; Coates, A S; Bajetta, E; Holmberg, S B; Dodwell, D; Mickiewicz, E; Andersen, J; Lønning, P E; Cocconi, G; Forbes, J; Castiglione, M; Stuart, N; Stewart, A; Fallowfield, L J; Bertelli, G; Hall, E; Bogle, R G; Carpentieri, M; Colajori, E; Subar, M; Ireland, E; Bliss, J M.

Lancet ; 369(9561): 559-70, 2007 Feb 17.

Artículo en Inglés | MEDLINE | ID: mdl-17307102

8.

Treatment of the axilla in patients with primary breast cancer and low burden axillary disease: Limitations of the evidence from randomised controlled trials.

Robertson, J F R; Herrod, P J J; Matthew, J; Kilburn, L S; Coles, C E; Bradbury, I.

Crit Rev Oncol Hematol ; 110: 74-80, 2017 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-28109407

9.

Relative potential for selection of quinolone-resistance-determining-region mutations in Streptococcus pneumoniae by gemifloxacin, gatifloxacin and moxifloxacin.

De Azavedo, J C S; Duncan, C L; Kilburn, L; Downar, J; Kong, B; Lad, S; Low, D E; Bast, D J.

J Chemother ; 18(4): 373-8, 2006 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-17024792

10.

Epirubicin dose and sequential hormonal therapy-Mature results of the HMFEC randomised phase III trial in premenopausal patients with node positive early breast cancer.

Coombes, R C; Kilburn, L S; Tubiana-Mathieu, N; Olmos, T; Van Bochove, A; Perez-Lopez, F R; Palmieri, C; Stebbing, J; Bliss, J M.

Eur J Cancer ; 60: 146-53, 2016 06.

Artículo en Inglés | MEDLINE | ID: mdl-27125966

11.

'Triple negative' breast cancer: a new area for phase III breast cancer clinical trials.

Kilburn, L S.

Clin Oncol (R Coll Radiol) ; 20(1): 35-9, 2008 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-17977700

12.

Combining fulvestrant (Faslodex) with continued oestrogen suppression in endocrine-sensitive advanced breast cancer: the SoFEA trial.

Dodwell, D; Coombes, G; Bliss, J M; Kilburn, L S; Johnston, S.

Clin Oncol (R Coll Radiol) ; 20(5): 321-4, 2008 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-18387790

13.

The Application and Feasibility of Using Routine Data Sources for Long-term Cancer Clinical Trial Follow-up.

Bhattacharya, I S; Morden, J P; Griffin, C; Snowdon, C; Brannan, R; Bliss, J M; Kilburn, L.

Clin Oncol (R Coll Radiol) ; 29(12): 796-798, 2017 12.

Artículo en Inglés | MEDLINE | ID: mdl-29107391

14.

Pacemaker doll.

Kilburn, L C.

Am J Nurs ; 74(12): 2229, 1974 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-4139899

15.

Insertion mutagenesis of the ferric pyoverdine receptor FpvA of Pseudomonas aeruginosa: identification of permissive sites and a region important for ligand binding.

Kilburn, L; Poole, K; Meyer, J M; Neshat, S.

J Bacteriol ; 180(24): 6753-6, 1998 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-9852025

16.

Genetic locus for streptolysin S production by group A streptococcus.

Nizet, V; Beall, B; Bast, D J; Datta, V; Kilburn, L; Low, D E; De Azavedo, J C.

Infect Immun ; 68(7): 4245-54, 2000 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-10858242

17.

Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: contributions of type II topoisomerase mutations and efflux to levels of resistance.

Bast, D J; Low, D E; Duncan, C L; Kilburn, L; Mandell, L A; Davidson, R J; de Azavedo, J C.

Antimicrob Agents Chemother ; 44(11): 3049-54, 2000 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-11036021

18.

Interspecies recombination contributes minimally to fluoroquinolone resistance in Streptococcus pneumoniae.

Bast, D J; de Azavedo, J C; Tam, T Y; Kilburn, L; Duncan, C; Mandell, L A; Davidson, R J; Low, D E.

Antimicrob Agents Chemother ; 45(9): 2631-4, 2001 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-11502541

19.

A nosocomial outbreak of fluoroquinolone-resistant Streptococcus pneumoniae.

Weiss, K; Restieri, C; Gauthier, R; Laverdière, M; McGeer, A; Davidson, R J; Kilburn, L; Bast, D J; de Azavedo, J; Low, D E.

Clin Infect Dis ; 33(4): 517-22, 2001 Aug 15.

Artículo en Inglés | MEDLINE | ID: mdl-11462189

Biblioteca Virtual en Salud

Hipertensión

Su selección (0)

Formato de exportación:

Exportar: